85
Participants
Start Date
July 4, 2017
Primary Completion Date
January 17, 2020
Study Completion Date
January 17, 2020
delta 9 tetrahydrocannabinol
A single cannabis cigarette (potency 12.5% delta 9 tetrahydrocannabinol) will be given to participants to smoke over a 10 minute period, ad libitum. If the cannabis cigarette is not smoked in its entirety, the remainder will be weighed to estimate dose.
placebo delta 9 tetrahydrocannabinol
A single placebo cannabis cigarette (\<0.03% delta 9 tetrahydrocannabinol) will be given to participants to smoke over a 10 minute period, ad libitum. If the placebo cannabis cigarette is not smoked in its entirety, the remainder will be weighed to estimate dose (as this is a double-blind study).
Alcohol
A single oral administration of an alcoholic beverage mixed in a 1:3 ratio of alcohol to tonic water to obtain a target blood alcohol content of 0.08mg%.
Placebo alcohol
A single oral administration of a beverage containing tonic water of the same volume as the alcoholic beverage.
Centre for Addiction and Mental Health, Toronto
Collaborators (1)
Canadian Institutes of Health Research (CIHR)
OTHER_GOV
Health Canada
OTHER_GOV
Centre for Addiction and Mental Health
OTHER